Potential missed opportunities for diagnosis of cryptococcosis and the association with mortality: A cohort study
Authors:
- Ana S. SalazarASAna S. Salazar
- Matthew R. KellerMKMatthew R. Keller
- Margaret A. OlsenMOMargaret A. Olsen
- Katelin B. NickelKNKatelin B. Nickel
- Ige A. GeorgeIGIge A. George
- Lindsey LarsonLLLindsey Larson
- William G. PowderlyWPWilliam G. Powderly
- Andrej SpecASAndrej Spec
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier in eClinicalMedicine
- Vol. 27
Abstract
No abstract availableKeywords
Funding Information
- Agency for Healthcare Research and Quality
- Institute of Clinical and Translational Sciences (UL1 TR002345)
- Foundation for Barnes-Jewish Hospital
- National Center for Advancing Translational Sciences
- Pfizer
- Alvin J. Siteman Cancer Center
- National Institutes of Health (UL1 TR002345)
- National Institutes of Health (R24 HS19455)
This publication has 39 references indexed in Scilit:
- Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South AfricaPLOS ONE, 2013
- Predictors of Mortality and Differences in Clinical Features among Patients with Cryptococcosis According to Immune StatusPLOS ONE, 2013
- Epidemiology of Cryptococcal Meningitis in the US: 1997–2009PLOS ONE, 2013
- Comparison and Temporal Trends of Three Groups with Cryptococcosis: HIV-Infected, Solid Organ Transplant, and HIV-Negative/Non-TransplantPLOS ONE, 2012
- Integrating Cryptococcal Antigen Screening and Pre-Emptive Treatment into Routine HIV CareJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South AfricaClinical Infectious Diseases, 2009
- Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDSAIDS, 2009
- Immune Reconstitution Inflammatory Syndrome: A ReappraisalClinical Infectious Diseases, 2009
- Cryptococcosis in Human Immunodeficiency Virus–Negative Patients in the Era of Effective Azole TherapyClinical Infectious Diseases, 2001
- Epidemiology of Human Immunodeficiency Virus–Associated Opportunistic Infections in the United States in the Era of Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2000